FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Senators Urge FDA: Do More to Resolve Drug Shortages

A bipartisan Senate letter urges FDA commissioner Robert Califf and HHS secretary Xavier Becerra to step up efforts to help resolve amoxicillin and ot...

latest-news-card-1
Biologics

FDA Grants, Denies Parts of Microbiome Petition

FDA grants one part and denies another part of a petition submitted by the Microbiome Therapeutic Innovation Group by publishing a final policy on fec...

latest-news-card-1
Human Drugs

Regeneron Files sBLA for Evkeeza in Young Children

FDA accepts for priority review a Regeneron Pharmaceuticals supplemental BLA for Evkeeza (evinacumab-dgnb) as an adjunct to other lipid-lowering thera...

latest-news-card-1
Federal Register

Voting Members Sought for Radiation Safety Panel

Federal Register notice: FDA requests nominations for voting members to serve on CDRHs Technical Electronic Product Radiation Safety Standards Committ...

latest-news-card-1
Federal Register

Draft Guide on Heartworm Drugs for Dogs

Federal Register notice: FDA makes available draft guidance #276 entitled Effectiveness of Anthelmintics: Specific Recommendations for Products Propos...

latest-news-card-1
Human Drugs

2 Admit Role in $38 Million Compounding Fraud

The Justice Department says the two owners of New Jersey-based Synergy Medical have admitted to participating in a conspiracy to commit healthcare fra...

latest-news-card-1
Medical Devices

Congress Should Pass VALID Act on LDTs: Advocates

The heads of two cancer advocacy organizations urge Congress to approve the VALID Act to regulate laboratory-developed tests offered without assurance...

latest-news-card-1
Biologics

Janssen Sues Amgen Over Stelara Biosimilar Plans

Janssen files a patent infringement suit against Amgen and its plans to seek FDA approval and market a biosimilar copy of Janssens blockbuster Stelara...

latest-news-card-1
Human Drugs

Merck in Keytruda Patent Dispute with Johns Hopkins

Merck sues Johns Hopkins University in Maryland federal court over patents Hopkins obtained following a research collaboration with Merck using Keytru...

latest-news-card-1
Human Drugs

Lillys Bebtelovimab Not Authorized in U.S.

FDA says Lillys bebtelovimab is not authorized for use in any U.S. region because it is not active against two key Omicron subvariants.